Stem cell-based treatment may represent a hope for the treatment of acute lung injury and
pulmonary fibrosis, and other chronic lung diseases, such as cystic fibrosis, asthma and …

Adult bone marrow contains a number of discrete populations of progenitor cells, including
endothelial, mesenchymal, and epithelial progenitor cells and fibrocytes. In the context of a …

Recent findings suggest that embryonic stem cells and stem cells derived from adult tissues,
including bone marrow and umbilical cord blood, could be utilized in repair and …

Chronic lung diseases, such as cystic fibrosis (CF), asthma, and chronic obstructive
pulmonary disease (COPD) are incurable and represent a very high social burden. Stem cell …

Recent studies have revealed that adult stem cells such as bone marrow-derived cells
contribute to lung tissue regeneration and protection, and thus administration of exogenous …

Lung injuries are leading causes of morbidity and mortality worldwide. Pulmonary diseases
such as asthma or chronic obstructive pulmonary disease characterized by loss of lung …

Mesenchymal stem cells (MSC) are a population of tissue‐resident adult progenitor cells
that were originally identified in bone marrow, but have now been identified in many organs …

The reported pluripotential capabilities of many human stem cell types has made them an
attractive area of research, given the belief they may hold considerable therapeutic potential …

Abstract Chronic Obstructive Pulmonary Disease (COPD) can be briefly described as air
flow limitation and chronic dyspnea associated to an inflammatory response of the …

Mesenchymal stem cells (MSCs) are a populace of non‐haematopoietic multipotent stromal
cells, which have the ability to differentiate into tissue derived from a single germ layer …